![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 19, 16567-16578, May 9, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Posttranslational Processing*
From the Departments of Antibacterials, Immunology and
Inflammation, and Exploratory Medicinal Sciences, Pfizer Global
Research and Development, Pfizer, Inc., Groton, Connecticut 06340
Stimulus-induced posttranslational processing of
human monocyte interleukin-1
(IL-1
) is accompanied by major
changes to the intracellular ionic environment, activation of
caspase-1, and cell death. Certain diarylsulfonylureas inhibit this
response, and are designated cytokine release inhibitory drugs (CRIDs). CRIDs arrest activated monocytes so that caspase-1 remains inactive and
plasma membrane latency is preserved. Affinity labeling with [14C]CRIDs and affinity chromatography on
immobilized CRID were used in seeking potential protein targets of
their action. Following treatment of intact human monocytes with an
epoxide-bearing [14C]CRID, glutathione
S-transferase (GST) Omega 1-1 was identified as a preferred
target. Moreover, labeling of this polypeptide correlated with
irreversible inhibition of ATP-induced IL-1
posttranslational processing. When extracts of human monocytic cells were chromatographed on a CRID affinity column, GST Omega 1-1 bound selectively to the
affinity matrix and was eluted by soluble CRID. Recombinant GST Omega
1-1 readily incorporated [14C]CRID epoxides, but labeling
was negated by co-incubation with S-substituted
glutathiones or by mutagenesis of the catalytic center
Cys32 to alanine. Peptide mapping by high performance
liquid chromatography-mass spectrometry also demonstrated that
Cys32 was the site of modification. Although
S-alkylglutathiones did not arrest ATP-induced IL-1
posttranslational processing or inhibit [14C]CRID
incorporation into cell-associated GST Omega 1-1, a glutathione-CRID adduct effectively demonstrated these attributes. Therefore, the ability of CRIDs to arrest stimulus-induced IL-1
posttranslational processing may be attributable to their interaction
with GST Omega 1-1.
To whom correspondence should be addressed: Dept. of
Antibacterials, Immunology and Inflammation, Mailstop 8220-2123, PGRD, Pfizer, Inc., Groton, CT 06340. Tel.: 860-441-5483; E-mail:
christopher_a_gabel@groton.pfizer.com.
This article has been cited by other articles:
![]() |
C. Burmeister, K. Luersen, A. Heinick, A. Hussein, M. Domagalski, R. D. Walter, and E. Liebau Oxidative stress in Caenorhabditis elegans: protective effects of the Omega class glutathione transferase (GSTO-1) FASEB J, February 1, 2008; 22(2): 343 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kolsch, S. Larionov, O. Dedeck, M. Orantes, G. Birkenmeier, W. S. T. Griffin, and D. R. Thal Association of the Glutathione S-transferase Omega-1 Ala140Asp Polymorphism With Cerebrovascular Atherosclerosis and Plaque-Associated Interleukin-1{alpha} Expression Stroke, October 1, 2007; 38(10): 2847 - 2850. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Franchi, T.-D. Kanneganti, G. R. Dubyak, and G. Nunez Differential Requirement of P2X7 Receptor and Intracellular K+ for Caspase-1 Activation Induced by Intracellular and Extracellular Bacteria J. Biol. Chem., June 29, 2007; 282(26): 18810 - 18818. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Verhoef, S. B. Kertesy, K. Lundberg, J. M. Kahlenberg, and G. R. Dubyak Inhibitory Effects of Chloride on the Activation of Caspase-1, IL-1{beta} Secretion, and Cytolysis by the P2X7 Receptor J. Immunol., December 1, 2005; 175(11): 7623 - 7634. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Whitbread, G. D. Mellick, P. A. Silburn, D. G. Le Couteur, and P. G. Board Glutathione transferase Omega class polymorphisms in Parkinson disease Neurology, May 25, 2004; 62(10): 1910 - 1911. [Full Text] [PDF] |
||||
![]() |
Y.-J. Li, S. A. Oliveira, P. Xu, E. R. Martin, J. E. Stenger, C. R. Scherzer, M. A. Hauser, W. K. Scott, G. W. Small, M. A. Nance, et al. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease Hum. Mol. Genet., December 15, 2003; 12(24): 3259 - 3267. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |